Table 1.
Baseline characteristics and clinical indication.
| Baseline characteristics | n = 15 |
|
| |
| Age (yrs) | 77.5 ± 6.5 |
| Male | 9 (60.0%) |
| BMI (kg/m2) | 26.5 ± 4.1 |
| Congestive heart failure | 3 (20.0%) |
| Hypertension | 11 (73.3%) |
| Age ≥ 75 years | 9 (60.0%) |
| Diabetes mellitus | 2 (13.3%) |
| Previous stroke/TIA | 8 (53.3%) |
| Vascular disease | 6 (40.0%) |
| Permanent AF | 11 (73.3%) |
| Serum creatinine (mg/dl) | 1.21 ± 0.63 |
| CHADS-VASc score | 4.7 ± 1.0 |
| HAS-BLED score | 3.1 ± 0.7 |
|
| |
| Indications | n = 15 |
|
| |
| Cerebral bleeding | 3 (20.0%) |
| Major bleeding | 5 (33.3%) |
| Minor bleeding | 3 (20.0%) |
| Recurrent stroke under OAC | 4 (26.7%) |
Numbers are mean ± SD or number (%). AF: atrial fibrillation, BMI: body mass index, OAC: oral anticoagulant, TIA: transient ischemic attack.